Novabridge Biosciences Adr stock is traded at $0.9081, with a volume of 940,088. It is down -10.09% in the last 24 hours and down -35.14% over the past month. NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
Previous Close:
$1.01
Open:
$1.01
24h Volume:
940,088
Relative Volume:
1.67
Market Cap:
$105.02M
Revenue:
$232.79M
Net Income/Loss:
-$88.69M
P/E Ratio:
-
EPS:
-$0.4419
Net Cash Flow:
-
1W Performance:
-24.01%
1M Performance:
-35.14%
6M Performance:
-59.64%
1Y Performance:
-78.33%
1-Day Range:
$0.00$0.00
1-Week Range:
$0.9$1.21
52-Week Range:
$0.9$5.19
Novabridge Biosciences Adr Stock (NBP) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS